Rare Disease Trial, Recruiting (NCT05865119)

Rare Disease Trial, Recruiting NCT05865119 Sponsor: Centre Chirurgical Marie Lannelongue Condition: Rare Disease

Printed from Voxsanity (voxsanity.com.au) — NCT05865119 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Rare Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 12 years of age or older
You have been diagnosed with a specific type of heart defect (a hole between the upper chambers of the heart, known as an atrial septal defect) and imaging tests (ultrasound or MRI) show that the right side of your heart has become enlarged beyond a certain size
Your medical team has recommended that you have this heart defect corrected, based on established heart guidelines
You are an adult who has been fully informed about the study and has signed a consent form agreeing to take part
If you are under 18, neither parent or legal guardian has objected to your information being used in the study
You are willing and able to attend follow-up appointments for the full length of the study
You are covered by a social security or health insurance plan

Who may not be able to join:

You are under legal guardianship or a supervised protection order (confirm with trial site)
You are currently detained or have restricted personal freedom
You are under a court-ordered protection measure (confirm with trial site)
You are currently pregnant or breastfeeding
You are already taking part in another clinical research study that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Sebastien HASCOËT, Hôpital Marie Lannelongue

Phone: +33140942429

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05865119

Sponsor: Centre Chirurgical Marie Lannelongue

Phase: Not Applicable

Status: Recruiting

Condition: Rare Disease

Trial contact: +33140942429

More information: https://clinicaltrials.gov/study/NCT05865119

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 12 years of age or older
You have been diagnosed with a specific type of heart defect (a hole between the upper chambers of the heart, known as an atrial septal defect) and imaging tests (ultrasound or MRI) show that the right side of your heart has become enlarged beyond a certain size
Your medical team has recommended that you have this heart defect corrected, based on established heart guidelines
You are an adult who has been fully informed about the study and has signed a consent form agreeing to take part
If you are under 18, neither parent or legal guardian has objected to your information being used in the study
You are willing and able to attend follow-up appointments for the full length of the study
You are covered by a social security or health insurance plan

Who may not be able to join:

You are under legal guardianship or a supervised protection order (confirm with trial site)
You are currently detained or have restricted personal freedom
You are under a court-ordered protection measure (confirm with trial site)
You are currently pregnant or breastfeeding
You are already taking part in another clinical research study that involves a treatment or intervention

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Centre Chirurgical Marie Lannelongue

Registry

ClinicalTrials.gov

Start date

12 May 2023

Est. completion

12 May 2024

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Number of participants meeting the primary net criteria in the 2 groups

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov